Skip to content
Homepage
Author:
20/20 Biolabs Inc.
Posted Date:
July 9, 2026
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
20/20 Biolabs Inc.
July 9, 2026
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
20/20 Biolabs Inc.
June 22, 2026
20/20 Biolabs’ Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
20/20 Biolabs Inc.
May 27, 2026
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
20/20 Biolabs Inc.
May 22, 2026
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
20/20 Biolabs Inc.
May 20, 2026
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
20/20 Biolabs Inc.
May 14, 2026
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
20/20 Biolabs Inc.
May 12, 2026
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
20/20 Biolabs Inc.
April 7, 2026
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
20/20 Biolabs Inc.
April 1, 2026
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
20/20 Biolabs Inc.
April 1, 2026
1
2
Next
